Cellectis SA (CLLS)
3.34
-0.14
(-4.02%)
USD |
NASDAQ |
Mar 20, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Cellectis Free Cash Flow (Quarterly) : -10.96M for Dec. 31, 2025
Free Cash Flow (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| DBV Technologies SA | -32.48M |
| EDAP TMS SA | -5.198M |
| Akari Therapeutics Plc | -2.102M |
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -79.87M |